ACOG Releases 2026 Maternal Immunization Schedule - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ACOG Releases 2026 Maternal Immunization Schedule

Thirteen other organizations endorsed guidance that extends across pregnancy, postpartum care, and lactation.

  • By

  • Kerri Miller

  • June 12, 2026

  • 3 min

Share

Objective:

To provide guidance for maternal immunizations for pregnant, postpartum, and lactating patients in the US.

Approach:
    Key Findings:
    • Influenza vaccination is recommended before the end of October and at any time during the influenza season.
    • COVID-19 vaccination is encouraged as soon as possible during any trimester.
    • A Tdap dose is recommended during each pregnancy at 27-36 weeks of gestation.
    • Only Pfizer’s Abrysvo is recommended for maternal RSV vaccination, ideally between 32-36 weeks of gestation.
    Interpretation:

    The schedule serves as a tool for healthcare providers to discuss the importance of immunizations with patients.

    Limitations:
    • The schedule is not inclusive of all treatments or methods of care.
    • It may not reflect the most recent evidence as it is reviewed regularly.
    Conclusion:

    The ACOG maternal immunization schedule aims to enhance maternal and infant health through vaccination.

    Sources:

Original Source(s)

ACOG Releases 2026 Maternal Immunization Schedule

  • by Kerri Miller

  • June 12, 2026

Related Content

FDA Approves Cefepime-Zidebactam Injection

Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.

Women Overdue for Cancer Screenings

More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.

Cancer Screening Gaps Seen in Sexual, Gender Minority Groups

A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.